Back to results
US 4,374,856 AGranted
Liver cytoprotection using PGE's
AssigneeThe Upjohn Company
InventorMary J. Ruwart
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treatment of hepatic diseases which comprises administering a hepatocytoprotective prostaglandin to a mammal who suffers from or is particularly succeptible to said hepatic diseases.
Claims7
A method for the treatment or prevention of a hepatic disease characterized by glutamic pyruvic transaminase (SGPT) activity of greater than 50 international units in a mammal suffering from or particularly susceptible to the development of said disease which comprises:
- systemically or orally administering to said mammal an amount of a hepatocytoprotective PGE-type prostaglandin effective to treat or prevent said disease.
Dependencies are inferred from the claim text.